| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Embryonic Stem Cells | 10 | 2014 | 55 | 1.900 |
Why?
|
| Induced Pluripotent Stem Cells | 7 | 2025 | 47 | 1.570 |
Why?
|
| Pluripotent Stem Cells | 8 | 2023 | 31 | 1.480 |
Why?
|
| Stem Cell Transplantation | 2 | 2016 | 39 | 0.890 |
Why?
|
| Fertilization | 10 | 2019 | 37 | 0.870 |
Why?
|
| Cell Culture Techniques | 6 | 2018 | 152 | 0.840 |
Why?
|
| Models, Animal | 3 | 2016 | 151 | 0.630 |
Why?
|
| Papio anubis | 1 | 2018 | 5 | 0.560 |
Why?
|
| Centrosome | 6 | 1999 | 30 | 0.540 |
Why?
|
| Cell Differentiation | 11 | 2025 | 638 | 0.530 |
Why?
|
| Stem Cells | 4 | 2016 | 152 | 0.530 |
Why?
|
| Animals | 49 | 2023 | 16992 | 0.480 |
Why?
|
| Spermatozoa | 9 | 2019 | 214 | 0.440 |
Why?
|
| Microtubules | 12 | 2019 | 121 | 0.440 |
Why?
|
| Primates | 3 | 2019 | 39 | 0.430 |
Why?
|
| Parkinson Disease | 1 | 2016 | 210 | 0.420 |
Why?
|
| Macaca mulatta | 7 | 2019 | 139 | 0.420 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2014 | 34 | 0.410 |
Why?
|
| Cerebral Cortex | 2 | 2025 | 306 | 0.400 |
Why?
|
| Oocytes | 13 | 2019 | 149 | 0.400 |
Why?
|
| Zygote | 8 | 2019 | 39 | 0.400 |
Why?
|
| Fertilization in Vitro | 10 | 2019 | 57 | 0.400 |
Why?
|
| Mast Cells | 6 | 2016 | 82 | 0.370 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2018 | 300 | 0.360 |
Why?
|
| G2 Phase | 2 | 2009 | 28 | 0.350 |
Why?
|
| Protein-Tyrosine Kinases | 5 | 2004 | 139 | 0.350 |
Why?
|
| Cells, Cultured | 9 | 2018 | 1621 | 0.340 |
Why?
|
| Nuclear Transfer Techniques | 4 | 2004 | 15 | 0.330 |
Why?
|
| DNA-Binding Proteins | 4 | 2009 | 561 | 0.330 |
Why?
|
| Mitochondria | 4 | 2009 | 523 | 0.320 |
Why?
|
| Francisella tularensis | 3 | 2016 | 116 | 0.310 |
Why?
|
| Electron Transport Complex III | 1 | 2009 | 13 | 0.310 |
Why?
|
| G1 Phase | 1 | 2009 | 31 | 0.310 |
Why?
|
| Homeodomain Proteins | 3 | 2025 | 150 | 0.310 |
Why?
|
| Cloning, Organism | 3 | 2004 | 22 | 0.300 |
Why?
|
| Enzyme Inhibitors | 5 | 2010 | 458 | 0.300 |
Why?
|
| Cell Cycle Proteins | 2 | 2009 | 241 | 0.290 |
Why?
|
| Mice | 19 | 2023 | 6644 | 0.290 |
Why?
|
| Transcription Factors | 5 | 2025 | 735 | 0.290 |
Why?
|
| Tularemia | 4 | 2018 | 115 | 0.290 |
Why?
|
| Immunohistochemistry | 8 | 2016 | 934 | 0.280 |
Why?
|
| Organoids | 2 | 2025 | 37 | 0.280 |
Why?
|
| Cytoskeleton | 5 | 2004 | 114 | 0.270 |
Why?
|
| Antineoplastic Agents | 9 | 2001 | 1019 | 0.270 |
Why?
|
| Polymerase Chain Reaction | 3 | 2016 | 455 | 0.270 |
Why?
|
| Pedigree | 1 | 2007 | 94 | 0.260 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2009 | 223 | 0.260 |
Why?
|
| Gene Expression | 4 | 2014 | 701 | 0.250 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2020 | 72 | 0.250 |
Why?
|
| Papio | 3 | 2016 | 22 | 0.250 |
Why?
|
| Organometallic Compounds | 3 | 2001 | 71 | 0.250 |
Why?
|
| Drug Design | 4 | 2004 | 186 | 0.240 |
Why?
|
| Blastocyst | 3 | 2008 | 50 | 0.240 |
Why?
|
| Mice, Inbred NOD | 3 | 2018 | 51 | 0.220 |
Why?
|
| Neurogenesis | 1 | 2025 | 63 | 0.220 |
Why?
|
| Apolipoprotein E4 | 1 | 2025 | 67 | 0.220 |
Why?
|
| Microscopy, Confocal | 9 | 2016 | 224 | 0.220 |
Why?
|
| Cell Cycle | 5 | 2011 | 346 | 0.210 |
Why?
|
| Nerve Net | 1 | 2025 | 101 | 0.210 |
Why?
|
| Mammals | 2 | 1995 | 112 | 0.210 |
Why?
|
| Enzyme Precursors | 1 | 2004 | 12 | 0.210 |
Why?
|
| Humans | 42 | 2025 | 43102 | 0.210 |
Why?
|
| Octamer Transcription Factor-3 | 3 | 2014 | 20 | 0.200 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 704 | 0.200 |
Why?
|
| Tubulin | 5 | 2001 | 96 | 0.200 |
Why?
|
| Macrophages | 2 | 2018 | 529 | 0.190 |
Why?
|
| Cell Nucleus | 6 | 2019 | 383 | 0.190 |
Why?
|
| Karyotyping | 3 | 2013 | 45 | 0.190 |
Why?
|
| Peptides | 1 | 2025 | 372 | 0.190 |
Why?
|
| Base Sequence | 6 | 2013 | 983 | 0.180 |
Why?
|
| Infertility, Male | 3 | 1997 | 47 | 0.180 |
Why?
|
| Mutation | 3 | 2025 | 1177 | 0.180 |
Why?
|
| Parthenogenesis | 3 | 2019 | 9 | 0.180 |
Why?
|
| Neurons | 2 | 2025 | 1263 | 0.170 |
Why?
|
| Vanadium Compounds | 1 | 2001 | 1 | 0.170 |
Why?
|
| Bone Regeneration | 1 | 2020 | 10 | 0.170 |
Why?
|
| Male | 26 | 2025 | 23409 | 0.170 |
Why?
|
| Quinazolines | 4 | 2002 | 38 | 0.170 |
Why?
|
| Cell Proliferation | 3 | 2025 | 1455 | 0.160 |
Why?
|
| Signal Transduction | 5 | 2018 | 2157 | 0.160 |
Why?
|
| DNA Primers | 2 | 2013 | 294 | 0.160 |
Why?
|
| Cell Line | 6 | 2009 | 1410 | 0.160 |
Why?
|
| Furans | 4 | 2001 | 40 | 0.160 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 | 2001 | 41 | 0.160 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2020 | 78 | 0.160 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2019 | 67 | 0.150 |
Why?
|
| Cattle | 8 | 2004 | 498 | 0.150 |
Why?
|
| Fibroblasts | 4 | 2010 | 281 | 0.140 |
Why?
|
| Embryo, Mammalian | 4 | 2011 | 157 | 0.140 |
Why?
|
| Phagosomes | 1 | 2018 | 33 | 0.140 |
Why?
|
| Receptors, IgE | 2 | 2016 | 22 | 0.140 |
Why?
|
| Bacterial Infections | 1 | 2018 | 45 | 0.140 |
Why?
|
| Osteogenesis | 2 | 2020 | 57 | 0.140 |
Why?
|
| Insulin-Secreting Cells | 2 | 2009 | 28 | 0.130 |
Why?
|
| Pyrans | 3 | 2001 | 10 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 11 | 2001 | 508 | 0.130 |
Why?
|
| Brain | 1 | 2025 | 1472 | 0.130 |
Why?
|
| Spiro Compounds | 3 | 2001 | 16 | 0.130 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2016 | 12 | 0.130 |
Why?
|
| Caspase 1 | 1 | 2016 | 16 | 0.130 |
Why?
|
| Fathers | 1 | 1997 | 38 | 0.130 |
Why?
|
| Female | 25 | 2019 | 24698 | 0.120 |
Why?
|
| Vaccines, Attenuated | 1 | 2016 | 75 | 0.120 |
Why?
|
| Intestines | 1 | 2016 | 71 | 0.120 |
Why?
|
| Protein Isoforms | 3 | 2014 | 139 | 0.120 |
Why?
|
| Patch-Clamp Techniques | 1 | 2016 | 228 | 0.120 |
Why?
|
| Bacterial Vaccines | 1 | 2016 | 129 | 0.110 |
Why?
|
| Rodentia | 1 | 1995 | 47 | 0.110 |
Why?
|
| Fertility | 1 | 1995 | 62 | 0.110 |
Why?
|
| Action Potentials | 1 | 2016 | 246 | 0.110 |
Why?
|
| Dopamine | 1 | 2016 | 275 | 0.110 |
Why?
|
| Sperm Head | 1 | 1994 | 10 | 0.110 |
Why?
|
| Reproduction | 1 | 1995 | 94 | 0.110 |
Why?
|
| Cell Division | 3 | 2006 | 311 | 0.100 |
Why?
|
| Apoptosis | 5 | 2014 | 1568 | 0.100 |
Why?
|
| RNA, Small Interfering | 2 | 2014 | 436 | 0.100 |
Why?
|
| Genetic Variation | 1 | 1996 | 430 | 0.100 |
Why?
|
| Myocytes, Cardiac | 2 | 2006 | 183 | 0.100 |
Why?
|
| RNA, Messenger | 4 | 2014 | 1271 | 0.100 |
Why?
|
| Embryo Transfer | 4 | 2011 | 33 | 0.100 |
Why?
|
| Osteoblasts | 1 | 2012 | 44 | 0.100 |
Why?
|
| Electric Stimulation | 1 | 2012 | 186 | 0.090 |
Why?
|
| Microinjections | 3 | 2004 | 50 | 0.090 |
Why?
|
| Mice, SCID | 3 | 2009 | 158 | 0.090 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2012 | 28 | 0.090 |
Why?
|
| Tissue Engineering | 1 | 2012 | 75 | 0.090 |
Why?
|
| Meiosis | 3 | 2004 | 67 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2007 | 652 | 0.090 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2001 | 17 | 0.090 |
Why?
|
| Haplorhini | 1 | 2011 | 23 | 0.090 |
Why?
|
| Chimera | 1 | 2011 | 18 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 2 | 2009 | 209 | 0.090 |
Why?
|
| Teratoma | 2 | 2009 | 10 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2009 | 296 | 0.080 |
Why?
|
| Genomic Instability | 1 | 2011 | 37 | 0.080 |
Why?
|
| Farnesyltranstransferase | 1 | 2010 | 4 | 0.080 |
Why?
|
| Progeria | 1 | 2010 | 9 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2004 | 200 | 0.080 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2010 | 40 | 0.080 |
Why?
|
| Models, Biological | 2 | 2009 | 712 | 0.080 |
Why?
|
| Phenotype | 2 | 2007 | 780 | 0.080 |
Why?
|
| Insulin | 2 | 2009 | 258 | 0.080 |
Why?
|
| Antimycin A | 1 | 2009 | 5 | 0.080 |
Why?
|
| Radiation, Ionizing | 1 | 2009 | 13 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2011 | 143 | 0.080 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2009 | 39 | 0.080 |
Why?
|
| Gamma Rays | 1 | 2009 | 27 | 0.080 |
Why?
|
| Sperm-Ovum Interactions | 4 | 1996 | 14 | 0.080 |
Why?
|
| Chromosomes, Human | 1 | 2009 | 37 | 0.080 |
Why?
|
| DNA Repair | 1 | 2010 | 198 | 0.070 |
Why?
|
| Immunity, Innate | 3 | 2018 | 171 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2009 | 986 | 0.070 |
Why?
|
| Genomic Imprinting | 1 | 2008 | 35 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 5 | 2006 | 256 | 0.070 |
Why?
|
| DNA, Mitochondrial | 2 | 2006 | 191 | 0.070 |
Why?
|
| Transplantation, Heterologous | 1 | 2007 | 98 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2009 | 883 | 0.060 |
Why?
|
| Cell Separation | 1 | 2007 | 94 | 0.060 |
Why?
|
| Reactive Oxygen Species | 1 | 2009 | 532 | 0.060 |
Why?
|
| Spasms, Infantile | 1 | 2025 | 1 | 0.060 |
Why?
|
| C-Peptide | 1 | 2005 | 7 | 0.060 |
Why?
|
| Flow Cytometry | 3 | 2002 | 411 | 0.060 |
Why?
|
| Pregnancy | 3 | 2011 | 1772 | 0.060 |
Why?
|
| Breast Neoplasms | 3 | 2004 | 1723 | 0.060 |
Why?
|
| Interneurons | 1 | 2025 | 65 | 0.060 |
Why?
|
| Receptors, CXCR4 | 1 | 2025 | 74 | 0.060 |
Why?
|
| Interleukin-4 | 2 | 2018 | 75 | 0.060 |
Why?
|
| Peritonitis | 2 | 2002 | 11 | 0.060 |
Why?
|
| Macaca | 1 | 2004 | 36 | 0.060 |
Why?
|
| Chromatin | 2 | 1996 | 186 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 4 | 2016 | 1869 | 0.060 |
Why?
|
| Microfilament Proteins | 1 | 2004 | 72 | 0.050 |
Why?
|
| Escherichia coli Infections | 2 | 2002 | 45 | 0.050 |
Why?
|
| Neuroglia | 1 | 2025 | 133 | 0.050 |
Why?
|
| Mitochondria, Heart | 1 | 2005 | 60 | 0.050 |
Why?
|
| Embryonic Development | 1 | 2004 | 83 | 0.050 |
Why?
|
| Cytoplasm | 3 | 2004 | 154 | 0.050 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2001 | 99 | 0.050 |
Why?
|
| Genome | 1 | 2004 | 149 | 0.050 |
Why?
|
| Protein Transport | 2 | 2016 | 296 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 1999 | 968 | 0.050 |
Why?
|
| Aneuploidy | 1 | 2003 | 24 | 0.050 |
Why?
|
| Electroporation | 1 | 2003 | 21 | 0.050 |
Why?
|
| Callithrix | 1 | 2023 | 15 | 0.050 |
Why?
|
| Zebrafish | 2 | 2001 | 146 | 0.050 |
Why?
|
| DNA | 4 | 2000 | 592 | 0.050 |
Why?
|
| Germ Cells | 1 | 2023 | 74 | 0.050 |
Why?
|
| Thrombopoietin | 1 | 2002 | 3 | 0.050 |
Why?
|
| P-Selectin | 1 | 2002 | 8 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 3 | 2016 | 694 | 0.050 |
Why?
|
| Transfection | 2 | 2018 | 532 | 0.050 |
Why?
|
| Cell Movement | 1 | 2025 | 655 | 0.040 |
Why?
|
| Leukocytes | 1 | 2002 | 80 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2002 | 117 | 0.040 |
Why?
|
| Blood Platelets | 1 | 2002 | 81 | 0.040 |
Why?
|
| Nervous System Neoplasms | 1 | 2001 | 2 | 0.040 |
Why?
|
| Vanadium | 1 | 2001 | 6 | 0.040 |
Why?
|
| Leukotriene C4 | 1 | 2000 | 6 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 1 | 2001 | 59 | 0.040 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2001 | 62 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2020 | 22 | 0.040 |
Why?
|
| Calcium Phosphates | 1 | 2020 | 15 | 0.040 |
Why?
|
| Calcification, Physiologic | 1 | 2020 | 18 | 0.040 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2000 | 44 | 0.040 |
Why?
|
| Phosphoproteins | 2 | 1999 | 206 | 0.040 |
Why?
|
| Fatty Alcohols | 1 | 2000 | 9 | 0.040 |
Why?
|
| Neutrophils | 1 | 2001 | 145 | 0.040 |
Why?
|
| Femur | 1 | 2020 | 47 | 0.040 |
Why?
|
| Vanadates | 1 | 2000 | 8 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2020 | 141 | 0.040 |
Why?
|
| Sperm Tail | 2 | 1996 | 4 | 0.040 |
Why?
|
| Materials Testing | 1 | 2020 | 101 | 0.040 |
Why?
|
| Disulfides | 2 | 1999 | 95 | 0.040 |
Why?
|
| Mitosis | 1 | 2001 | 114 | 0.040 |
Why?
|
| Glioblastoma | 1 | 2001 | 74 | 0.040 |
Why?
|
| Extrachromosomal Inheritance | 1 | 1999 | 2 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 2019 | 65 | 0.040 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 1999 | 8 | 0.040 |
Why?
|
| Genes, Dominant | 1 | 1999 | 20 | 0.040 |
Why?
|
| Collagen | 1 | 2020 | 181 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 1999 | 94 | 0.040 |
Why?
|
| Immunoglobulin E | 1 | 1999 | 61 | 0.040 |
Why?
|
| Aniline Compounds | 1 | 1998 | 28 | 0.040 |
Why?
|
| Arabidopsis Proteins | 1 | 1999 | 46 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1999 | 267 | 0.040 |
Why?
|
| Nitriles | 1 | 1998 | 81 | 0.040 |
Why?
|
| Molecular Sequence Data | 4 | 2005 | 1542 | 0.040 |
Why?
|
| Mycobacterium bovis | 1 | 2018 | 14 | 0.030 |
Why?
|
| Immune Evasion | 1 | 2018 | 17 | 0.030 |
Why?
|
| Mycobacterium Infections | 1 | 2018 | 16 | 0.030 |
Why?
|
| Endosomes | 1 | 2018 | 33 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2018 | 57 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 1999 | 189 | 0.030 |
Why?
|
| Sulfhydryl Reagents | 1 | 1997 | 6 | 0.030 |
Why?
|
| Dithiothreitol | 1 | 1997 | 18 | 0.030 |
Why?
|
| Cell Surface Extensions | 1 | 2016 | 9 | 0.030 |
Why?
|
| Micromanipulation | 1 | 1996 | 12 | 0.030 |
Why?
|
| Morula | 1 | 1996 | 2 | 0.030 |
Why?
|
| Estrus | 1 | 1996 | 12 | 0.030 |
Why?
|
| Transcription, Genetic | 3 | 2006 | 592 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2016 | 109 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2016 | 53 | 0.030 |
Why?
|
| Immunity | 1 | 2016 | 61 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2016 | 91 | 0.030 |
Why?
|
| Rats | 2 | 2020 | 3735 | 0.030 |
Why?
|
| Spleen | 1 | 2016 | 204 | 0.030 |
Why?
|
| Cell Communication | 1 | 2016 | 114 | 0.030 |
Why?
|
| Ikaros Transcription Factor | 3 | 1999 | 9 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2020 | 1766 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2016 | 269 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 2005 | 1180 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2018 | 386 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 1996 | 575 | 0.030 |
Why?
|
| Marsupialia | 1 | 1994 | 6 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2012 | 1035 | 0.030 |
Why?
|
| Blastomeres | 2 | 2009 | 9 | 0.030 |
Why?
|
| Paclitaxel | 2 | 2004 | 64 | 0.030 |
Why?
|
| Actins | 1 | 1995 | 164 | 0.030 |
Why?
|
| Chromosomes | 2 | 2004 | 43 | 0.030 |
Why?
|
| Neoplasms | 2 | 2001 | 1377 | 0.020 |
Why?
|
| Electromagnetic Fields | 1 | 2012 | 10 | 0.020 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2004 | 134 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2012 | 37 | 0.020 |
Why?
|
| Cell Survival | 3 | 2001 | 945 | 0.020 |
Why?
|
| Child | 4 | 2001 | 3443 | 0.020 |
Why?
|
| Benzimidazoles | 2 | 2006 | 43 | 0.020 |
Why?
|
| Models, Molecular | 3 | 2000 | 876 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2012 | 65 | 0.020 |
Why?
|
| Nuclear Proteins | 2 | 2004 | 333 | 0.020 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 2 | 2001 | 6 | 0.020 |
Why?
|
| Janus Kinase 3 | 2 | 2001 | 36 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 2011 | 44 | 0.020 |
Why?
|
| Cell Death | 1 | 2012 | 278 | 0.020 |
Why?
|
| Fluorescent Dyes | 2 | 2006 | 182 | 0.020 |
Why?
|
| Embryo Implantation | 1 | 2011 | 31 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 2 | 2006 | 515 | 0.020 |
Why?
|
| Syndrome | 1 | 2010 | 73 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2009 | 8 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2009 | 10 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2009 | 11 | 0.020 |
Why?
|
| Chromosomes, Human, X | 1 | 2009 | 23 | 0.020 |
Why?
|
| Subcellular Fractions | 2 | 1999 | 77 | 0.020 |
Why?
|
| Zinc Fingers | 2 | 1999 | 28 | 0.020 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2009 | 11 | 0.020 |
Why?
|
| Regenerative Medicine | 1 | 2009 | 10 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2009 | 25 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2000 | 157 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2009 | 148 | 0.020 |
Why?
|
| Telomerase | 1 | 2009 | 42 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2009 | 240 | 0.020 |
Why?
|
| Protein Conformation | 2 | 2000 | 416 | 0.020 |
Why?
|
| Calcium | 2 | 2002 | 491 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2008 | 181 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2001 | 1124 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2010 | 1285 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 1996 | 210 | 0.020 |
Why?
|
| Carbocyanines | 1 | 2006 | 14 | 0.020 |
Why?
|
| Secretory Vesicles | 1 | 2005 | 20 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2005 | 83 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2006 | 75 | 0.010 |
Why?
|
| Infant | 2 | 1999 | 1175 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2006 | 222 | 0.010 |
Why?
|
| Genome, Human | 1 | 2006 | 144 | 0.010 |
Why?
|
| Wiskott-Aldrich Syndrome Protein Family | 1 | 2004 | 3 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2004 | 8 | 0.010 |
Why?
|
| Molecular Motor Proteins | 1 | 2004 | 9 | 0.010 |
Why?
|
| Child, Preschool | 2 | 1999 | 1546 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2004 | 60 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2004 | 74 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2008 | 403 | 0.010 |
Why?
|
| RNA | 1 | 2006 | 266 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 213 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2002 | 24 | 0.010 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2002 | 1 | 0.010 |
Why?
|
| Platelet Factor 4 | 1 | 2002 | 2 | 0.010 |
Why?
|
| Cell Degranulation | 1 | 2002 | 10 | 0.010 |
Why?
|
| Cell Aggregation | 1 | 2002 | 17 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2002 | 86 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2002 | 127 | 0.010 |
Why?
|
| Cytogenetic Analysis | 1 | 2001 | 5 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2001 | 25 | 0.010 |
Why?
|
| Neoplasm, Residual | 1 | 2001 | 17 | 0.010 |
Why?
|
| Remission Induction | 1 | 2001 | 19 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2001 | 9 | 0.010 |
Why?
|
| Vincristine | 1 | 2001 | 14 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2001 | 35 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2001 | 10 | 0.010 |
Why?
|
| Pentanones | 1 | 2001 | 4 | 0.010 |
Why?
|
| Hydroxybutyrates | 1 | 2001 | 3 | 0.010 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2001 | 28 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 2001 | 44 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2001 | 40 | 0.010 |
Why?
|
| Chick Embryo | 1 | 2001 | 79 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2001 | 116 | 0.010 |
Why?
|
| Calcimycin | 1 | 2000 | 11 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2001 | 55 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2001 | 127 | 0.010 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2000 | 11 | 0.010 |
Why?
|
| Eosinophils | 1 | 2000 | 24 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 2000 | 35 | 0.010 |
Why?
|
| Drug Stability | 1 | 2001 | 129 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2001 | 80 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 518 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2001 | 280 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2001 | 152 | 0.010 |
Why?
|
| HL-60 Cells | 1 | 2000 | 33 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2000 | 138 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1999 | 88 | 0.010 |
Why?
|
| Cell Extracts | 1 | 1999 | 16 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 1999 | 12 | 0.010 |
Why?
|
| Binding Sites | 1 | 2001 | 671 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 1999 | 73 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1999 | 109 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2001 | 506 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 1999 | 95 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2002 | 460 | 0.010 |
Why?
|
| Fatty Acid Desaturases | 1 | 1999 | 4 | 0.010 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 1999 | 9 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2001 | 384 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2001 | 570 | 0.010 |
Why?
|
| Tumor Stem Cell Assay | 1 | 1998 | 32 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1999 | 114 | 0.010 |
Why?
|
| Cell Lineage | 1 | 1999 | 104 | 0.010 |
Why?
|
| Isoxazoles | 1 | 1998 | 15 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1999 | 93 | 0.010 |
Why?
|
| Blood Proteins | 1 | 1999 | 77 | 0.010 |
Why?
|
| Prognosis | 1 | 2001 | 861 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2001 | 307 | 0.010 |
Why?
|
| Plant Proteins | 1 | 1999 | 102 | 0.010 |
Why?
|
| Amphibians | 1 | 1997 | 9 | 0.010 |
Why?
|
| Sea Urchins | 1 | 1997 | 11 | 0.010 |
Why?
|
| Lysophosphatidylcholines | 1 | 1997 | 22 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 611 | 0.010 |
Why?
|
| Acrosome | 1 | 1996 | 2 | 0.010 |
Why?
|
| Cytochalasin B | 1 | 1996 | 4 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1997 | 159 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 1999 | 228 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2001 | 1600 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1999 | 321 | 0.010 |
Why?
|
| Insemination, Artificial | 1 | 1996 | 10 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1999 | 386 | 0.010 |
Why?
|
| Injections | 1 | 1996 | 42 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1999 | 465 | 0.010 |
Why?
|
| Culture Media | 1 | 1996 | 96 | 0.010 |
Why?
|
| Parents | 1 | 1999 | 370 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1997 | 457 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1999 | 1081 | 0.010 |
Why?
|
| Centrioles | 1 | 1994 | 2 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1996 | 403 | 0.010 |
Why?
|
| Adult | 2 | 1999 | 13872 | 0.010 |
Why?
|
| Risk Factors | 1 | 2001 | 3994 | 0.010 |
Why?
|
| Adolescent | 1 | 1999 | 6081 | 0.000 |
Why?
|